The Advice & Research teams objective is to provide a broad list of high quality, industry leading companies from which an investor can assemble a well-diversified portfolio
[PMC free article: PMC4658457] [PubMed: 26537941] 50
Drugs such as liraglutide, semaglutide, dulaglutide, and the dual GLP-1/GIP receptor agonist tirzepatide demonstrate robust efficacy for weight reduction and glycemic optimization
TB-500 (synthetic TB4) has been clinically tested for its wound healing potential, with the following two studies worth noting: In a randomized, double-blind, placebo-controlled study with dose escalation, patients suffering from venous stasis ulcers were administered synthetic TB4 locally over a period of 84 days
Clinical studies in elderly humans confirm these findings
Creatine Monohydrate: For muscle maintenance, recovery, and cognitive benefits